Remdesivir, which is being used on Covid-19 patients in several countries including the USA, will be launched in the Bangladesh market this month.
Mohammad Salahuddin, deputy director of the Directorate General of Drug Administration, said this.
On Tuesday, the Directorate General of Drug Administration gave permission to another pharmaceutical company to produce the potential Covid-19 drug.
On Monday, it gave permission to seven pharmaceutical companies. The companies are -- Beximco, Beacon, Eskayef (SK-F), Opsonin, Incepta, Square and Healthcare.
Remdesivir is being used on Covid-19 patients in several countries including the US. It has a history to work well against the SARS and Ebola virus.